Short Interest in Medpace Holdings, Inc. (NASDAQ:MEDP) Grows By 16.8%

Medpace Holdings, Inc. (NASDAQ:MEDP) was the recipient of a large growth in short interest in the month of February. As of February 28th, there was short interest totalling 1,460,000 shares, a growth of 16.8% from the February 13th total of 1,250,000 shares. Based on an average daily trading volume, of 292,800 shares, the days-to-cover ratio is presently 5.0 days. Currently, 5.8% of the shares of the company are short sold.

Medpace Stock Performance

NASDAQ MEDP opened at $319.63 on Friday. The business’s fifty day moving average is $338.25 and its 200 day moving average is $340.10. Medpace has a fifty-two week low of $302.01 and a fifty-two week high of $459.77. The company has a market capitalization of $9.74 billion, a PE ratio of 25.31, a price-to-earnings-growth ratio of 3.81 and a beta of 1.47.

Medpace (NASDAQ:MEDP) last posted its quarterly earnings data on Monday, February 10th. The company reported $3.67 earnings per share for the quarter, beating analysts’ consensus estimates of $2.96 by $0.71. Medpace had a return on equity of 51.48% and a net margin of 19.17%. On average, sell-side analysts forecast that Medpace will post 12.29 EPS for the current year.

Wall Street Analyst Weigh In

Separately, Robert W. Baird upped their price objective on Medpace from $354.00 to $362.00 and gave the company a “neutral” rating in a research report on Monday, January 27th. Seven analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat, Medpace has an average rating of “Hold” and a consensus price target of $381.44.

Institutional Trading of Medpace

A number of hedge funds and other institutional investors have recently modified their holdings of the company. R Squared Ltd bought a new position in Medpace in the 4th quarter worth $30,000. SBI Securities Co. Ltd. purchased a new position in shares of Medpace in the fourth quarter valued at about $31,000. Stone House Investment Management LLC bought a new position in shares of Medpace in the third quarter worth about $33,000. Jones Financial Companies Lllp grew its position in shares of Medpace by 2,750.0% during the fourth quarter. Jones Financial Companies Lllp now owns 114 shares of the company’s stock worth $38,000 after purchasing an additional 110 shares in the last quarter. Finally, Lindbrook Capital LLC raised its stake in Medpace by 27.6% during the 4th quarter. Lindbrook Capital LLC now owns 134 shares of the company’s stock valued at $45,000 after purchasing an additional 29 shares during the period. 77.98% of the stock is owned by hedge funds and other institutional investors.

Medpace Company Profile

Medpace Holdings, Inc engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance.